🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Single-Arm Clinical Study of Furmonertinib (160mg) Combined with Intrathe...
Status
Recruiting
Location
CANGZHOU People's Hospital
Start Date
2025-12-22
Trial ID
NCT07304739
Treatments Being Tested
The aim of this phase Ⅱ study is to evaluate the efficacy and safety of Fur...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-12-09
Trial ID
NCT05255406
Treatments Being Tested
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639
This is a phase II, prospective, multi-centre study. To assess the efficacy...
Status
Recruiting
Location
Sichuan cancer hospital
Start Date
2023-12-31
Trial ID
NCT06192849
Treatments Being Tested
This Phase II randomized study is to explore the efficacy and safety of Fur...
Status
Unknown
Location
Sun yat-sen University Cancer Center
Start Date
2021-06-01
Trial ID
NCT04970693
Treatments Being Tested
To evaluate the efficacy, safety, recurrence site, recurrence pattern and r...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-07-15
Trial ID
NCT06674343
Treatments Being Tested
This is a prospective, randomised, uncontrolled phase II clinical trial pla...
Status
Recruiting
Location
Changhai Hospital
Start Date
2024-05-01
Trial ID
NCT06394674
Treatments Being Tested
This is a Phase Ib clinical study conducted in China to evaluate the treatm...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-02
Trial ID
NCT06868732
Treatments Being Tested
This multicenter study evaluates the efficacy and safety of furmonertinib 1...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-01
Trial ID
NCT07365410
Treatments Being Tested
The goal of this clinical trial is to explore the efficacy and safety of do...
Status
Recruiting
Location
The Second Affiliated Hospital of Nanchang University
Start Date
2026-02-15
Trial ID
NCT07398599